Skip to content

Where next for HIV vaccines and antibody therapies?

Dr Mark Feinberg, President of IAVI

Antibiotics to prevent STIs – for or against?

Professor Jean-Michel Molina presenting to HIVR4P 2021.

As AIDS recedes, HIV stigma evolves in rural South Africa

Rural South Africa. Image by Mario R. Creative Commons licence.

African studies explore reasons to start, stick with or stop PrEP

Home page of the Jilinde PrEP programme in Kenya

HIV self-testing increases uptake of HIV testing, but with poorer linkage to care

Domizia Salusest | www.domiziasalusest.com

The Buenos Aires patient: Argentinian woman controls HIV for at least 12 years after stopping treatment

Buenos Aires, Argentina. Andrea Leopardi/Unsplash

Products to prevent both pregnancy and HIV begin to emerge

Dr Alexandra Minnis presenting to HIVR4P 2021.

Nearly a million have started taking PrEP worldwide – only a third of UNAIDS’ 2020 target

Kate Segal presenting to HIVR4P 2021.

New ethical obligations for researchers in places where existing HIV prevention services are inadequate

Peter Godfrey-Faussett (top right) presenting at HIVR4P 2021.